T.S. Mok
Department of Clinical Oncology
The Chinese University of Hong Kong
Prince of Wales Hospital
Shatin
China
Name/email consistency: high
- A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma. Mok, T.S., Leung, T.W., Lee, S.D., Chao, Y., Chan, A.T., Huang, A., Lui, M.C., Yeo, W., Chak, K., Johnston, A., Johnson, P. Cancer Chemother. Pharmacol. (1999)